Key Takeaways
-
DSOs provide administrative support to dental practices, while private equity supplies the capital that often backs those organizations. Knowing the difference is essential when you evaluate buyers.
-
Atlanta’s dental market is highly active, with multiple PE-backed acquisitions in 2026 that signal strong buyer demand and competitive pressure.
-
Most DSO deals blend cash at close, equity rollover, and performance-based earnouts. Sellers need to model real after-tax outcomes across all components.
-
Identifying whether a buyer is PE-owned through branding, growth pace, or shared billing helps sellers negotiate from a position of strength.
-
McLerran & Associates helps Atlanta-area dentists compare DSO and private-buyer paths with side-by-side valuations and a structured process that can improve outcomes. Schedule your free, confidential discovery call today.
The Confusion Between DSO And Private Equity In Atlanta
Atlanta-area dental practice owners routinely hear “DSO” and “private equity” used interchangeably by colleagues, brokers, and even the buyers approaching them. That confusion is understandable and costly. In Georgia, nearly one-quarter of dentists are affiliated with DSOs, and the private equity firms fueling national consolidation also fund local Atlanta groups. The labels blur because the same capital often sits behind many of the buyers in the room.
This guide cuts through the jargon. It explains who actually buys dental practices, how deals are structured, and how to identify which type of entity is approaching you. That clarity helps you make the biggest financial decision of your career with clarity and confidence.
Schedule a free, confidential discovery call with McLerran & Associates to get a clear view of your options before any buyer reaches your table.
DSO Vs. Private Equity: What Dentists Need To Know
A DSO is an operating model. A Dental Service Organization provides non-clinical business and administrative support, such as HR, marketing, compliance, billing, and supply chain, so dentists can focus on patient care. When you affiliate with a DSO, you join a support infrastructure rather than selling directly to a financial investor.
Private equity is a capital structure. Private equity firms are investment companies that raise capital from institutional investors to buy stakes in businesses, including DSOs. Their goal is to scale those businesses and sell later for a profit. When a PE firm backs a DSO, it provides the capital that fuels acquisitions and sets the return timeline that shapes every deal term.
Where DSO and private equity overlap. Most large DSOs are backed by private equity. Some PE firms also invest directly in dental groups or create platform companies. Some DSOs remain dentist-led or independently owned. The legal and economic structure of a deal can matter more than the marketing label on the offer.
Why this distinction matters for sellers. When you sell to a “DSO,” you often sell to a PE-backed platform whose investors expect a return within a defined window. That timeline shapes the deal structure, the equity they offer, and the growth pressure they apply after closing. Knowing who sits behind the buyer helps you understand what you can negotiate.
The Atlanta Dental Market Landscape
Atlanta has become one of the most active dental consolidation markets in the Southeast. Georgia’s population growth, particularly in the Atlanta metro corridor and surrounding suburbs, has created steady demand for dental services, which attracts PE-backed buyers.
Recent activity illustrates the pace of consolidation and the pattern of institutional capital moving into the region:
-
A national DSO added McCarthy Dentistry in Marietta, Georgia in March 2026, expanding its Atlanta-metro footprint.
-
A DSO acquired 11 pediatric dental and orthodontic practices across Georgia and South Carolina in July 2026, following a $170 million recapitalization led by an institutional lender, which signals PE-scale capital entering the Southeast specialty market.
-
Brightworks Dentistry unified its Atlanta-area practices in Dunwoody, Buckhead, and Downtown Atlanta under a single brand in July 2026, a hallmark move of a maturing corporate dental group.
-
T Management, an Atlanta-based DSO, secured private equity investment to scale its local practices, showing how homegrown groups can attract institutional capital.
The takeaway: Atlanta is a competitive market. Owners who understand the landscape and who is actually buying can negotiate from strength. Owners who do not understand these dynamics can leave significant value on the table.
Deal Structures Compared: Cash, Equity, And Earnout
When a PE-backed DSO buys your practice, the purchase price is rarely all cash. Most deals combine three components, and each carries a different risk profile and payout timeline.
Cash at close is the guaranteed portion you receive when the deal closes. In current transactions, this typically represents 60% to 80% of total deal value.
Equity rollover is the portion of sale proceeds reinvested into the buyer’s platform rather than paid in cash. Rollover equity is effectively standard in DSO transactions and often represents 15% to 30% of total consideration. This equity can be held at different levels:
-
JV-level equity: Stock in your specific practice entity. It may provide distributions but usually has a lower ceiling on upside.
-
Holding-company equity: Stock in the parent DSO. It offers no distributions but higher potential upside if the platform is sold or recapitalized.
The third component, the earnout, is a performance-based payment. It is paid over a defined period, typically 3 to 5 years, if the practice hits specified EBITDA targets. EBITDA means earnings before interest, taxes, depreciation, and amortization, and it is a common measure of operating profitability. Earnouts commonly represent 15% to 30% of total deal value and are contingent on performance, which makes them a less certain component of an offer. Poorly structured earnouts with unrealistic targets or no pro-rata provision can be punitive if integration takes longer than expected.
The table below summarizes how each component compares in typical range, risk, and payout timing.
|
Deal Component |
Typical Range |
Risk Profile |
When You Receive It |
|---|---|---|---|
|
Cash at close |
60%–80% of total value |
Guaranteed |
At closing |
|
Equity rollover |
15%–30% of total value |
Illiquid; depends on DSO success |
At exit or recapitalization |
|
Earnout |
15%–30% of total value |
Contingent on performance |
Over 3–5 years post-close |
Because as much as 40% of a DSO deal can be paid in equity and earnout rather than cash, you are effectively buying stock in the DSO. McLerran & Associates produces multi-year, multi-structure financial forecasts that quantify real after-tax proceeds across cash, equity, and earnout scenarios over 3-, 5-, 7-, and 10-year horizons. Owners can compare actual outcomes instead of relying on headline numbers.
How To Tell If A Dental Office Is PE-Owned
Sellers often need to identify whether a potential buyer or competitor is PE-owned. The signals below work best when you consider them together as a pattern, not as single proof points.
-
Corporate branding: Multiple locations operating under one unified name or website, as when Atlanta-area practices unified under a single brand in July 2026, often signal a maturing corporate group from a seller’s perspective.
-
“Supported by” or “partnered with” language: Practices that describe themselves as “supported by” a management organization rather than independently owned often use a DSO or MSO structure, which can change how a buyer approaches negotiations.
-
Rapid location growth: Groups that have acquired 10 or more practices in a short period are almost certainly PE-backed, since that pace usually requires institutional capital and a defined growth plan.
-
Shared billing addresses: Several “independent” practices sharing a single billing address or parent company often indicate centralized back-office functions, which can reveal a hidden platform buyer.
-
State dental board and corporate records: Corporate ownership filings can show whether a management services organization holds the practice’s assets, which informs how sophisticated the buyer may be.
-
Associate turnover patterns: High associate turnover or rotating dentists can indicate corporate management structures, which may affect culture and retention after a sale.
If you are selling, knowing whether you are negotiating with an independent dentist or a PE-backed platform with professional negotiators forms the foundation of your negotiating position.
DSO Vs. Private Buyer: Which Path Fits Your Practice?
Not every practice belongs in a DSO deal, and not every owner wants one. The right path can depend on your practice’s size and your personal goals.
Private buyer (doctor-to-doctor): For practices under roughly $1.5 million in revenue, a private buyer often fits better. DSO and group buyers typically require at least $400,000–$600,000 of adjusted EBITDA before they will seriously consider a practice, and many smaller practices do not meet that threshold. Private buyers value practices on seller’s discretionary earnings (SDE), which is the total financial benefit a single owner-operator receives from the business. This approach can favor smaller, efficient practices. These deals also tend to close with more cash at closing and a shorter transition period.
DSO/PE affiliation: In contrast, for practices above $1.5 million in revenue, DSO affiliation can be more lucrative. PE-backed buyers pay higher multiples on EBITDA, and larger practices can command premium valuations. The trade-off includes more complex deal structures and equity rollover. It also typically requires a post-close employment commitment that often spans 3 to 5 years.
The “Venn diagram middle” ($1.5M–$3M revenue): Owners in this range can genuinely go either way. This is where McLerran & Associates’ side-by-side valuation becomes most valuable. The firm quantifies what your practice is worth in both markets so you choose with full information rather than a guess.
|
Practice Revenue |
Likely Best Path |
Why |
|---|---|---|
|
Under $1.5M |
Private buyer |
Cleaner cash exit; DSOs may not underwrite at this size |
|
$1.5M–$3M |
Either, depending on goals |
Side-by-side valuation needed to compare real outcomes |
|
$3M+ |
DSO/PE affiliation |
Higher multiples; platform-level buyer interest |
McLerran & Associates actively runs both transition paths for clients. That approach gives owners a genuine comparison rather than a broker steering them toward a single familiar path.
Schedule a free, confidential discovery call with McLerran & Associates to find out which path fits your practice size, goals, and timeline.
Why Representation Matters In Atlanta’s Active Market
A dentist sells once in a lifetime. A DSO negotiates deals every week. That asymmetry is one of the main risks in any practice transition, and it grows in a hot market like Atlanta, where PE-backed buyers compete aggressively for quality assets.
Going alone or working with a generalist broker can put you at a disadvantage. Comparing a DSO or private equity offer requires evaluating many factors on the same assumptions: cash at closing, rollover equity, earnouts, debt, taxes, management fees, restrictive covenants, governance, clinical authority, and post-close compensation. That level of analysis usually calls for dental-specific M&A expertise rather than a generalist’s instinct.
McLerran & Associates levels the table. The firm’s track record shows the impact of a dedicated sell-side process:
-
Approximately 2,000 successful practice sales completed
-
Approximately $2 billion in closed transaction volume
-
More than 10,000 practices evaluated
-
An approximately 85%–90% transaction rate, versus an industry norm of approximately 35%–40%
-
Approximately 30% higher valuations on average than owners achieve selling alone
McLerran’s Atlanta office, led by Matt Sutton, provides local market expertise backed by a national platform. The firm vets buyers rigorously, blacklists poorly run DSOs, and creates competition through a structured, auction-like process that typically generates around 10 offers per listing. You maintain control of the narrative around your EBITDA instead of letting the buyer define it.
Georgia’s corporate practice of dentistry doctrine also adds a layer of structural complexity. DSOs in Georgia must operate through management agreements rather than direct ownership of the clinical entity, and transactions must be structured as MSO arrangements that comply with state law. Navigating that structure without experienced representation can introduce legal and financial risk that surfaces long after closing.
Questions To Ask Any DSO Or PE Buyer
Before you sign anything, ask these questions and expect clear, specific answers.
-
Who is the private equity backer, and what is their track record? Ask for the specific PE firm, its fund size, its dental portfolio, and its typical hold period. Evasion is a red flag.
-
What percentage of the deal is equity versus cash? A DSO might offer a strong headline multiple, while 25%–30% may be rolled equity and 5%–10% may be earnout tied to post-close performance. The real cash-at-close figure can be much lower than the number presented.
-
What is the earnout structure, and is it non-punitive? Ask whether targets are realistic, whether a pro-rata provision applies so a near-miss still pays most of the earnout, and when the earnout period starts.
-
How will my staff and patients be affected? Ask about staffing changes, clinical protocols, insurance participation, and patient communication. The highest bidder may not be the right buyer for your culture.
-
What is the post-close integration plan? Ask what systems will change, who manages the back office, and what your role looks like after 90 days, 1 year, and 3 years.
McLerran & Associates vets every buyer before they reach your table and has blacklisted DSOs known for poor post-close environments. You should not need to discover basic issues after signing a letter of intent.
Conclusion And Next Steps
DSO describes an operating model. Private equity describes the capital behind it. In Atlanta’s active consolidation market, misunderstanding that distinction or overlooking how the deal is structured can be expensive. Knowing who is actually buying your practice and what the deal is worth across cash, equity, and earnout can be some of the main factors in maximizing your outcome.
The right path depends on your practice’s size and your goals. As discussed, smaller practices often align better with private buyers, while larger practices may benefit more from DSO or PE affiliation. Practices in the middle range deserve a genuine side-by-side comparison rather than a guess.
McLerran & Associates offers both transition paths and its Atlanta office, led by Matt Sutton, provides local expertise backed by approximately 2,000 successful sales and approximately $2 billion in closed volume. Whether you are exploring a transition now or planning for the future, the firm acts as your sell-side advisor and advocate, creating competition, helping you find the right fit, and working to improve your outcome.
Unsure whether selling is right for you yet? Join the McLerran M&A Summit (October 29–30, 2026) and get educated before you decide. Attendees receive 4 CE credits and a complimentary practice valuation, which is a $2,500 value.
Schedule a free, confidential discovery call with McLerran & Associates. Call (512) 900-7989 or email info@dentaltransitions.com to get started.
Frequently Asked Questions
What Is The Difference Between A DSO And A Private Equity Firm In Dentistry?
A DSO (Dental Service Organization) is an operating model, a company that provides non-clinical business and administrative support to dental practices, handling functions like billing, HR, marketing, and compliance. Private equity is a capital structure, a group of investment firms that raise money from institutional investors and deploy it to buy stakes in businesses, often including DSOs. The two terms describe different aspects of a buyer: one describes how a dental group operates, and the other describes who funds it. Most large DSOs are backed by private equity, but some PE-backed entities do not operate through a DSO structure, and some DSOs do not have PE backing. When you evaluate a buyer, understanding both the operating model and the capital structure behind it can help you negotiate more effectively.
How Can I Tell If A Dental Practice Or Buyer Is Private Equity-Owned?
Several signals can indicate PE or corporate ownership. Practices operating under a unified corporate brand across multiple locations, groups that have grown rapidly through acquisitions, and buyers who use language like “supported by” or “partnered with” a management organization are common indicators. Shared billing addresses across multiple “independent” practices can also signal centralized corporate back-office functions. For buyers approaching you directly, ask which entity is purchasing the business or assets, who owns the management company, and what equity is offered after closing. If the buyer is evasive about ownership structure or the identity of its private equity backer, that behavior itself provides useful information. A sell-side advisor like McLerran & Associates vets buyers before they reach your table so you are not negotiating blind.
What Is The Typical Deal Structure When Selling A Dental Practice To A DSO?
As detailed in the deal structures section above, most DSO deals combine cash at close, equity rollover, and an earnout. Cash at close is the guaranteed portion paid when the transaction closes. Equity rollover is the portion of sale proceeds reinvested into the buyer’s platform rather than paid in cash, and it remains illiquid until the DSO is sold or recapitalized. The earnout is a performance-based payment made over a defined post-close period, contingent on the practice meeting specified profitability targets. Each component carries different risk and timing, so modeling the after-tax outcome across all three can help you compare offers accurately. McLerran & Associates builds these models so owners can look beyond headline numbers.
Should I Sell My Atlanta Dental Practice To A DSO Or A Private Buyer?
The answer depends primarily on your practice’s size and your personal goals. Practices generating under roughly $1.5 million in annual revenue are often better suited to a doctor-to-doctor sale, where the buyer is an individual dentist purchasing with conventional or SBA financing. These deals tend to close with more cash at closing, involve a shorter transition period, and preserve the practice’s culture more directly. Practices above $1.5 million in revenue are more likely to attract DSO and PE-backed buyers, who pay higher multiples on EBITDA and can underwrite larger, more complex transactions. Owners in the $1.5 million to $3 million revenue range can genuinely go either way and often benefit from a side-by-side valuation that quantifies their practice’s worth in both markets before choosing a path.
Why Does It Matter Who Represents Me When Selling To A DSO In Atlanta?
A dentist sells once in a career. A DSO negotiates acquisitions every week. That information asymmetry is a central risk in any practice transition. Without experienced sell-side representation, you negotiate against professional buyers who set the terms, define the EBITDA, and structure the equity in ways that favor them. A generalist broker who knows only a few DSOs can create limited competitive tension and weaker underwriting, which often leads to less aggressive bids. McLerran & Associates runs a structured, auction-like process that typically generates around 10 offers per listing, creates genuine competition among vetted buyers, and defends the agreed valuation through due diligence so the deal is less likely to be renegotiated down at the finish line. The firm’s approximately 85%–90% transaction rate, versus an industry norm of approximately 35%–40%, reflects what a full, dental-specific sell-side process can deliver.
